ALDEYRA THERAPEUTICS INC's ticker is ALDX and the CUSIP is 01438T106. A total of 73 filers reported holding ALDEYRA THERAPEUTICS INC in Q1 2020. The put-call ratio across all filers is 1.07 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2022 | $0 | – | 11 | -89.0% | 0.00% | – |
Q3 2020 | $0 | – | 100 | 0.0% | 0.00% | – |
Q2 2020 | $0 | – | 100 | 0.0% | 0.00% | – |
Q1 2020 | $0 | – | 100 | 0.0% | 0.00% | – |
Q4 2019 | $0 | – | 100 | 0.0% | 0.00% | – |
Q3 2019 | $0 | -100.0% | 100 | -99.7% | 0.00% | -100.0% |
Q3 2018 | $420,000 | +431.6% | 30,530 | +205.3% | 0.10% | +216.1% |
Q2 2018 | $79,000 | – | 10,000 | – | 0.03% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Prosight Management, LP | 1,155,300 | $4,621,000 | 2.77% |
Knoll Capital Management, LLC | 759,405 | $3,038,000 | 1.67% |
ACUTA CAPITAL PARTNERS, LLC | 500,000 | $2,000,000 | 0.84% |
Perceptive Advisors | 19,807,758 | $79,232,000 | 0.61% |
Mesirow Financial Investment Management, Inc. | 48,711 | $195,000 | 0.56% |
Ghost Tree Capital, LLC | 300,000 | $1,200,000 | 0.43% |
Stonepine Capital Management, LLC | 200,000 | $800,000 | 0.37% |
APOGEM CAPITAL LLC | 86,730 | $347,000 | 0.23% |
JOHNSON & JOHNSON | 394,834 | $1,579,000 | 0.18% |
Affinity Asset Advisors, LLC | 100,759 | $403,000 | 0.15% |